21h
Discover key insights from Basilea Pharmaceutica AG's Q4 2024 earnings call. Learn about robust revenue growth, FDA approvals, and pipeline advancements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback